CONCORD2
Consultancy in Coordinated Care for Rare Diseases Partners: NIHR, patients and carers, healthcare professionals
The Challenge
Rare disease patients often require care from multiple professionals across different locations, leading to fragmented care and reduced quality.
Our Consultancy Approach
-
Co-chaired CONCORD2 study, building on the original CONCORD research
-
Advised on study design, evidence review, and methodology
-
Facilitated patient, carer, and professional engagement through interviews, focus groups, and surveys
-
Supported policy recommendations, including cost and value-for-money assessments
Our Impact
- Identified effective models of care coordination
- Informed NHS policy and future rare disease care models
- Enabled patients and carers to influence research and service design
Get in touch
Let’s Turn Your Cogs